Diamedica Therapeutics Stock Widgets and Gadgets
DMAC Stock | USD 2.45 0.03 1.24% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- DMAC DiaMedica Therapeutics
- Latest DiaMedica Up as Stroke Study Dosing Begins Post Relaunch
- DMAC 2.45 0.03
- Low 2.41
- High 2.56
- Alpha -0.26
- Beta 0.98
- Return On Equity -0.47
- Return On Asset -0.3
- Current Valuation 39.36 M
- Shares Outstanding 37.96 M
- Shares Owned By Insiders 26.65 %
- Shares Owned By Institutions 22.01 %
- Number Of Shares Shorted 202.17 K
- Price To Earning (3.52) X
- Price To Book 1.80 X
- EBITDA (21.24 M)
- Net Income (19.38 M)
- Cash And Equivalents 38.44 M
- Cash Per Share 1.45 X
- Total Debt 400 K
- Current Ratio 25.50 X
- Book Value Per Share 1.34 X
- Cash Flow From Operations (18.73 M)
- Short Ratio 4.75 X
- Earnings Per Share (0.60) X
- Price To Earnings To Growth (0.07) X
- Target Price 7.0
- Number Of Employees 18
- Beta 1.74
- Market Capitalization 91.86 M
- Total Asset 54.16 M
- Retained Earnings (115.56 M)
- Working Capital 50.89 M
- Current Asset 5.24 M
- Current Liabilities 1.05 M
- Net Asset 54.16 M
- Accumulation Distribution 0.0586
- Daily Balance Of Power 0.2
- Rate Of Daily Change 1.01
- Day Median Price 2.49
- Day Typical Price 2.47
- Market Facilitation Index 0.15
- Price Action Indicator (0.02)
- Period Momentum Indicator 0.03
- Relative Strength Index 25.28
Market Snapshot Widget Example
DAX Index Germany | 18,089 0.27 | |
Taiwan Weighted Taiwan | 20,132 2.72 | |
PSI 20 Stock Portugal | 6,530 0.95 | |
CROBEX Croatia | 2,786 0.05 | |
Budapest SE Hungary | 66,377 0.66 | |
IDX 30 Jakarta Indonesia | 472.42 0.44 | |
ISEQ 20 Price Ireland | 1,652 0.95 | |
NYSE Comp USA | 17,758 0.19 | |
Tel Aviv 35 Israel | 1,938 1.13 | |
Coreshares Index Tracker South Afric | 1,056 1.44 | |
IPC MEXICO Mexico | 56,464 0.3 | |
KL Technology Malaysia | 64.16 1.55 | |
IBEX 35 Index Spain | 11,028 0.43 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,580 0.02 | |
SPASX Dividend Opportunities Australia | 1,657 0.08 | |
HNX 30 Vietnam | 481.21 2.05 | |
Bucharest BET-NG Romania | 1,202 0.1 | |
AMS Small Cap Netherlands | 1,189 1.29 | |
Oslo Exchange Mutual Norway | 1,304 1.04 | |
BEL Small Belgium | 9,020 0.03 | |
RTSI Index Russia | 1,172 0.66 | |
Basic Materials Brazil | 5,814 0.49 | |
Swiss Leader Price Switzerland | 1,857 0.69 | |
Fondo Mutuo ETF Chile | 1,416 0.34 | |
Athens General Comp Greece | 1,449 0.06 | |
Stock Exchange Of Thailand | 1,361 0.27 | |
PX Prague Stock Czech Repub | 1,557 0.49 | |
THE PHILIPPINE STOCK Philippines | 6,573 1.01 | |
WIG 30 Poland | 3,051 0.89 | |
BIST Electricity Turkey | 592.91 0.41 |
Investing Ideas
In addition to having DiaMedica Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare DiaMedica Therapeutics
Compare DiaMedica Therapeutics To Peers
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaMedica Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.Note that the DiaMedica Therapeutics information on this page should be used as a complementary analysis to other DiaMedica Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for DiaMedica Stock analysis
When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is DiaMedica Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Return On Assets (0.30) | Return On Equity (0.47) |
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.